A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Tolerability of GRF6021 Infusions in Subjects with Parkinson's Disease and Cognitive Impairment.

Project: Research

StatusActive
Effective start/end date8/04/1930/04/20

Keywords

  • Neurological disorders
  • Parkinson's disease
  • Cognitive Impairment
  • Clinical trial